INS and diabetes mellitus: In the study by Dos Santos et al., in an 11-year-old patient with uncontrolled diabetes (despite treatment with high doses of insulin, metformin and pioglitazone), the use of empagliflozin resulted in a decrease in HbA1c from 10.5% to 7.7% after 7 months and reduced the insulin dose.